A pilot clinical phase II trial MemSID: Acute and durable changes of red blood cells of sickle cell disease patients on memantine treatment.
EJHaem
; 1(1): 23-34, 2020 Jul.
Article
in En
| MEDLINE
| ID: mdl-35847705
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
EJHaem
Year:
2020
Document type:
Article